Insmed
INSM
#730
Rank
C$45.54 B
Marketcap
C$213.55
Share price
-0.60%
Change (1 day)
89.48%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -C$1.55 Billion

According to Insmed's latest financial reports the company's current earnings are C$0.44 Billion. In 2024 the company made an earning of -C$1.13 Billion a decrease over its 2023 earnings that were of -C$0.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$1.55 Billion36.64%
2024 -C$1.13 Billion23.71%
2023 -C$0.92 Billion45.77%
2022 -C$0.63 Billion15.83%
2021 -C$0.55 Billion50.19%
2020 -C$0.37 Billion16.4%
2019 -C$0.31 Billion-23.9%
2018 -C$0.41 Billion59.35%
2017 -C$0.26 Billion8.52%
2016 -C$0.24 Billion47.25%
2015 -C$0.16 Billion34.53%
2014 -C$0.12 Billion58.83%
2013 -C$74.71 Million35.14%
2012 -C$55.29 Million-31.92%
2011 -C$81.21 Million854.92%
2010 -C$8.51 Million-105.22%
2009 C$0.16 B-905.06%
2008 -C$20.23 Million-27.31%
2007 -C$27.83 Million-62.41%
2006 -C$74.02 Million98.19%
2005 -C$37.35 Million0.03%
2004 -C$37.34 Million159.07%
2003 -C$14.42 Million-69.31%
2002 -C$46.96 Million
2000 -C$42.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.35 B-1,591.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
C$13.45 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$6.07 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-C$0.35 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-C$31.64 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
C$6 M-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA